Cargando…

Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response

In this study, radiotherapy was combined with the gene electrotransfer (GET) of plasmid encoding shRNA against melanoma cell adhesion molecule (pMCAM) with dual action, which was a vascular-targeted effect mediated by the silencing of MCAM and an immunological effect mediated by the presence of plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kranjc Brezar, Simona, Mrak, Valter, Bosnjak, Masa, Savarin, Monika, Sersa, Gregor, Cemazar, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157247/
https://www.ncbi.nlm.nih.gov/pubmed/32204304
http://dx.doi.org/10.3390/vaccines8010135
_version_ 1783522340368285696
author Kranjc Brezar, Simona
Mrak, Valter
Bosnjak, Masa
Savarin, Monika
Sersa, Gregor
Cemazar, Maja
author_facet Kranjc Brezar, Simona
Mrak, Valter
Bosnjak, Masa
Savarin, Monika
Sersa, Gregor
Cemazar, Maja
author_sort Kranjc Brezar, Simona
collection PubMed
description In this study, radiotherapy was combined with the gene electrotransfer (GET) of plasmid encoding shRNA against melanoma cell adhesion molecule (pMCAM) with dual action, which was a vascular-targeted effect mediated by the silencing of MCAM and an immunological effect mediated by the presence of plasmid DNA in the cytosol-activating DNA sensors. The effects and underlying mechanisms of therapy were evaluated in more immunogenic B16F10 melanoma and less immunogenic TS/A carcinoma. The silencing of MCAM potentiated the effect of irradiation (IR) in both tumor models. Combined therapy resulted in 81% complete responses (CR) in melanoma and 27% CR in carcinoma. Moreover, after the secondary challenge of cured mice, 59% of mice were resistant to challenge with melanoma cells, and none were resistant to carcinoma. Combined therapy reduced the number of blood vessels; induced hypoxia, apoptosis, and necrosis; and reduced cell proliferation in both tumor models. In addition, the significant increase of infiltrating immune cells was observed in both tumor models but more so in melanoma, where the expression of IL-12 and TNF-α was determined as well. Our results indicate that the combined therapy exerts both antiangiogenic and immune responses that contribute to the antitumor effect. However, tumor immunological status is crucial for a sufficient immune system contribution to the overall antitumor effect.
format Online
Article
Text
id pubmed-7157247
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71572472020-05-01 Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response Kranjc Brezar, Simona Mrak, Valter Bosnjak, Masa Savarin, Monika Sersa, Gregor Cemazar, Maja Vaccines (Basel) Article In this study, radiotherapy was combined with the gene electrotransfer (GET) of plasmid encoding shRNA against melanoma cell adhesion molecule (pMCAM) with dual action, which was a vascular-targeted effect mediated by the silencing of MCAM and an immunological effect mediated by the presence of plasmid DNA in the cytosol-activating DNA sensors. The effects and underlying mechanisms of therapy were evaluated in more immunogenic B16F10 melanoma and less immunogenic TS/A carcinoma. The silencing of MCAM potentiated the effect of irradiation (IR) in both tumor models. Combined therapy resulted in 81% complete responses (CR) in melanoma and 27% CR in carcinoma. Moreover, after the secondary challenge of cured mice, 59% of mice were resistant to challenge with melanoma cells, and none were resistant to carcinoma. Combined therapy reduced the number of blood vessels; induced hypoxia, apoptosis, and necrosis; and reduced cell proliferation in both tumor models. In addition, the significant increase of infiltrating immune cells was observed in both tumor models but more so in melanoma, where the expression of IL-12 and TNF-α was determined as well. Our results indicate that the combined therapy exerts both antiangiogenic and immune responses that contribute to the antitumor effect. However, tumor immunological status is crucial for a sufficient immune system contribution to the overall antitumor effect. MDPI 2020-03-19 /pmc/articles/PMC7157247/ /pubmed/32204304 http://dx.doi.org/10.3390/vaccines8010135 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kranjc Brezar, Simona
Mrak, Valter
Bosnjak, Masa
Savarin, Monika
Sersa, Gregor
Cemazar, Maja
Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
title Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
title_full Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
title_fullStr Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
title_full_unstemmed Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
title_short Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
title_sort intratumoral gene electrotransfer of plasmid dna encoding shrna against melanoma cell adhesion molecule radiosensitizes tumors by antivascular effects and activation of an immune response
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157247/
https://www.ncbi.nlm.nih.gov/pubmed/32204304
http://dx.doi.org/10.3390/vaccines8010135
work_keys_str_mv AT kranjcbrezarsimona intratumoralgeneelectrotransferofplasmiddnaencodingshrnaagainstmelanomacelladhesionmoleculeradiosensitizestumorsbyantivasculareffectsandactivationofanimmuneresponse
AT mrakvalter intratumoralgeneelectrotransferofplasmiddnaencodingshrnaagainstmelanomacelladhesionmoleculeradiosensitizestumorsbyantivasculareffectsandactivationofanimmuneresponse
AT bosnjakmasa intratumoralgeneelectrotransferofplasmiddnaencodingshrnaagainstmelanomacelladhesionmoleculeradiosensitizestumorsbyantivasculareffectsandactivationofanimmuneresponse
AT savarinmonika intratumoralgeneelectrotransferofplasmiddnaencodingshrnaagainstmelanomacelladhesionmoleculeradiosensitizestumorsbyantivasculareffectsandactivationofanimmuneresponse
AT sersagregor intratumoralgeneelectrotransferofplasmiddnaencodingshrnaagainstmelanomacelladhesionmoleculeradiosensitizestumorsbyantivasculareffectsandactivationofanimmuneresponse
AT cemazarmaja intratumoralgeneelectrotransferofplasmiddnaencodingshrnaagainstmelanomacelladhesionmoleculeradiosensitizestumorsbyantivasculareffectsandactivationofanimmuneresponse